Loading component...

Piedmont Newton launches minimally invasive treatment for enlarged prostate

Covington, Ga. (November 20, 2026) – Piedmont Newton Hospital has expanded access to advanced urologic care with the launch of its new Aquablation therapy program, offering men with benign prostatic hyperplasia (BPH), commonly known as an enlarged prostate, an innovative treatment option close to home.
“Bringing Aquablation therapy to Piedmont Newton reflects our commitment to expanding access to advanced, patient-centered care,” said CEO Lindsey Petrini. “Men in our community living with symptoms of BPH now have access to a minimally invasive therapy that can improve their quality of life.”
BPH is one of the most common conditions affecting aging men and can lead to frequent urination, difficulty emptying the bladder, weak urinary flow, and disrupted sleep. Treatment approaches include lifestyle changes, medication, and surgery.
Aquablation therapy is the first and only robotic-assisted, ultrasound-guided treatment for BPH. Using real-time imaging and a heat-free waterjet, the technology precisely removes excess prostate tissue while helping preserve quality of life. Clinical studies show the procedure can provide significant, long-lasting symptom relief, including improved urinary flow, regardless of prostate size. Aquablation procedures typically take less than an hour, and most patients return home the same day.
Piedmont Newton’s program officially launched last month, when urologist Robert Scott Libby, MD, successfully performed the hospital’s first three Aquablation procedures.
For more information about Aquablation therapy or urology services at Piedmont Newton, visit Piedmont.org or speak with your primary care provider about a referral.